TY - BOOK PY - 2003 DA - 2003// TI - A public health approach to antiretroviral treatment: overcoming constraints PB - World Health Organization CY - Geneva ID - ref1 ER - TY - BOOK PY - 2010 DA - 2010// TI - Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach (2010 version) PB - World Health Organization CY - Geneva, Switzerland ID - ref2 ER - TY - JOUR AU - Reynolds, S. J. AU - Nakigozi, G. AU - Newell, K. AU - Ndyanabo, A. AU - Galiwongo, R. AU - Boaz, I. AU - Quinn, T. C. AU - Gray, R. AU - Wawer, M. AU - Serwadda, D. PY - 2009 DA - 2009// TI - Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda JO - Aids VL - 23 UR - https://doi.org/10.1097/QAD.0b013e3283262a78 DO - 10.1097/QAD.0b013e3283262a78 ID - Reynolds2009 ER - TY - BOOK PY - 2006 DA - 2006// TI - Antiretroviral therapy for HIV infection adults and adolescents in resource limited settings: towards universal access PB - World Health Organization CY - Geneva ID - ref4 ER - TY - JOUR AU - Havlir, D. AU - Cheeseman, S. H. AU - McLaughlin, M. AU - Murphy, R. AU - Erice, A. AU - Spector, S. A. AU - Greenough, T. C. AU - Sullivan, J. L. AU - Hall, D. AU - Myers, M. PY - 1995 DA - 1995// TI - High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection JO - J Infect Dis VL - 171 UR - https://doi.org/10.1093/infdis/171.3.537 DO - 10.1093/infdis/171.3.537 ID - Havlir1995 ER - TY - JOUR AU - Wainberg, M. A. PY - 2003 DA - 2003// TI - HIV resistance to nevirapine and other non-nucleoside reverse transcriptase inhibitors JO - J Acquir Immune Defic Syndr VL - 34 UR - https://doi.org/10.1097/00126334-200309011-00002 DO - 10.1097/00126334-200309011-00002 ID - Wainberg2003 ER - TY - JOUR AU - Quiros-Roldan, E. AU - Torti, C. AU - Lapadula, G. AU - Ladisa, N. AU - Micheli, V. AU - Patroni, A. AU - Cusato, M. AU - Pierotti, P. AU - Tirelli, V. AU - Uccelli, M. C. AU - Di Giambenedetto, S. AU - Castelnuovo, F. AU - Gargiulo, F. AU - Manca, N. AU - Carosi, G. PY - 2007 DA - 2007// TI - Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy JO - AIDS Patient Care STDS VL - 21 UR - https://doi.org/10.1089/apc.2005.0037 DO - 10.1089/apc.2005.0037 ID - Quiros-Roldan2007 ER - TY - JOUR AU - de Vries-Sluijs, T. E. AU - Dieleman, J. P. AU - Arts, D. AU - Huitema, A. D. AU - Beijnen, J. H. AU - Schutten, M. AU - van der Ende, M. E. PY - 2003 DA - 2003// TI - Low nevirapine plasma concentrations predict virological failure in an unselected HIV-1-infected population JO - Clin Pharmacokinet VL - 42 UR - https://doi.org/10.2165/00003088-200342060-00009 DO - 10.2165/00003088-200342060-00009 ID - de Vries-Sluijs2003 ER - TY - BOOK PY - 2012 DA - 2012// TI - Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services ID - ref9 ER - TY - JOUR AU - Saitoh, A. AU - Sarles, E. AU - Capparelli, E. AU - Aweeka, F. AU - Kovacs, A. AU - Burchett, S. K. AU - Wiznia, A. AU - Nachman, S. AU - Fenton, T. AU - Spector, S. A. PY - 2007 DA - 2007// TI - CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children JO - Aids VL - 21 UR - https://doi.org/10.1097/QAD.0b013e3282ef9695 DO - 10.1097/QAD.0b013e3282ef9695 ID - Saitoh2007 ER - TY - JOUR AU - Lamorde, M. AU - Byakika-Kibwika, P. AU - Okaba-Kayom, V. AU - Ryan, M. AU - Coakley, P. AU - Boffito, M. AU - Namakula, R. AU - Kalemeera, F. AU - Colebunders, R. AU - Back, D. AU - Khoo, S. AU - Merry, C. PY - 2011 DA - 2011// TI - Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin JO - J Antimicrob Chemother VL - 66 UR - https://doi.org/10.1093/jac/dkq411 DO - 10.1093/jac/dkq411 ID - Lamorde2011 ER - TY - JOUR AU - Penzak, S. R. AU - Kabuye, G. AU - Mugyenyi, P. AU - Mbamanya, F. AU - Natarajan, V. AU - Alfaro, R. M. AU - Kityo, C. AU - Formentini, E. AU - Masur, H. PY - 2007 DA - 2007// TI - Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda JO - HIV Med VL - 8 UR - https://doi.org/10.1111/j.1468-1293.2007.00432.x DO - 10.1111/j.1468-1293.2007.00432.x ID - Penzak2007 ER - TY - JOUR AU - Bangsberg, D. R. AU - Acosta, E. P. AU - Gupta, R. AU - Guzman, D. AU - Riley, E. D. AU - Harrigan, P. R. AU - Parkin, N. AU - Deeks, S. G. PY - 2006 DA - 2006// TI - Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness JO - Aids VL - 20 UR - https://doi.org/10.1097/01.aids.0000199825.34241.49 DO - 10.1097/01.aids.0000199825.34241.49 ID - Bangsberg2006 ER - TY - JOUR AU - Nachega, J. B. AU - Hislop, M. AU - Dowdy, D. W. AU - Lo, M. AU - Omer, S. B. AU - Regensberg, L. AU - Chaisson, R. E. AU - Maartens, G. PY - 2006 DA - 2006// TI - Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults JO - J Acquir Immune Defic Syndr VL - 43 UR - https://doi.org/10.1097/01.qai.0000225015.43266.46 DO - 10.1097/01.qai.0000225015.43266.46 ID - Nachega2006 ER - TY - JOUR AU - Sempa, J. AU - Ssennono, M. AU - Kuznik, A. AU - Lamorde, M. AU - Sowinski, S. AU - Semeere, A. AU - Hermans, S. AU - Castelnuovo, B. AU - Manabe, Y. C. PY - 2012 DA - 2012// TI - Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda JO - BMC Public Health VL - 12 UR - https://doi.org/10.1186/1471-2458-12-736 DO - 10.1186/1471-2458-12-736 ID - Sempa2012 ER - TY - JOUR AU - Hugen, P. W. AU - Burger, D. M. AU - Aarnoutse, R. E. AU - Baede, P. A. AU - Nieuwkerk, P. T. AU - Koopmans, P. P. AU - Hekster, Y. A. PY - 2002 DA - 2002// TI - Therapeutic drug monitoring of HIV-protease inhibitors to assess noncompliance JO - Ther Drug Monit VL - 24 UR - https://doi.org/10.1097/00007691-200210000-00001 DO - 10.1097/00007691-200210000-00001 ID - Hugen2002 ER - TY - JOUR AU - Hugen, P. W. AU - Langebeek, N. AU - Burger, D. M. AU - Zomer, B. AU - van Leusen, R. AU - Schuurman, R. AU - Koopmans, P. P. AU - Hekster, Y. A. PY - 2002 DA - 2002// TI - Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring JO - J Acquir Immune Defic Syndr VL - 30 UR - https://doi.org/10.1097/00126334-200207010-00009 DO - 10.1097/00126334-200207010-00009 ID - Hugen2002 ER - TY - JOUR AU - L’Homme, R. F. AU - Muro, E. P. AU - Droste, J. A. AU - Wolters, L. R. AU - van Ewijk-Beneken Kolmer, N. W. AU - Schimana, W. AU - Burger, D. M. PY - 2008 DA - 2008// TI - Therapeutic drug monitoring of nevirapine in resource-limited settings JO - Clin Infect Dis VL - 47 UR - https://doi.org/10.1086/592694 DO - 10.1086/592694 ID - L’Homme2008 ER - TY - JOUR AU - van Heeswijk, R. P. AU - Veldkamp, A. I. AU - Mulder, J. W. AU - Meenhorst, P. L. AU - Beijnen, J. H. AU - Lange, J. M. AU - Hoetelmans, R. M. PY - 2001 DA - 2001// TI - Saliva as an alternative body fluid for therapeutic drug monitoring of the nonnucleoside reverse transcription inhibitor nevirapine JO - Ther Drug Monit VL - 23 UR - https://doi.org/10.1097/00007691-200106000-00012 DO - 10.1097/00007691-200106000-00012 ID - van Heeswijk2001 ER - TY - JOUR AU - Rakhmanina, N. Y. AU - Capparelli, E. V. AU - van den Anker, J. N. AU - Williams, K. AU - Sever, J. L. AU - Spiegel, H. M. AU - Soldin, S. J. PY - 2007 DA - 2007// TI - Nevirapine concentration in nonstimulated saliva: an alternative to plasma sampling in children with human immunodeficiency virus infection JO - Ther Drug Monit VL - 29 UR - https://doi.org/10.1097/FTD.0b013e31803258ed DO - 10.1097/FTD.0b013e31803258ed ID - Rakhmanina2007 ER - TY - JOUR AU - Hamers, R. L. AU - Oyomopito, R. AU - Kityo, C. AU - Phanuphak, P. AU - Siwale, M. AU - Sungkanuparph, S. AU - Conradie, F. AU - Kumarasamy, N. AU - Botes, M. E. AU - Sirisanthana, T. AU - Abdallah, S. AU - Li, P. C. AU - Ngorima, N. AU - Kantipong, P. AU - Osibogun, A. AU - Lee, C. K. AU - Stevens, W. S. AU - Kamarulzaman, A. AU - Derdelinckx, I. AU - Chen, Y. M. AU - Schuurman, R. AU - van Vugt, M. AU - Rinke de Wit, T. F. PY - 2012 DA - 2012// TI - Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance–HIV drug resistance in sub-Saharan Africa and the Asia-Pacific JO - Int J Epidemiol VL - 41 UR - https://doi.org/10.1093/ije/dyq192 DO - 10.1093/ije/dyq192 ID - Hamers2012 ER - TY - JOUR AU - Sigaloff, K. C. AU - Hamers, R. L. AU - Wallis, C. L. AU - Kityo, C. AU - Siwale, M. AU - Ive, P. AU - Botes, M. E. AU - Mandaliya, K. AU - Wellington, M. AU - Osibogun, A. AU - Stevens, W. S. AU - van Vugt, M. AU - de Wit, T. F. PY - 2011 DA - 2011// TI - Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa JO - J Acquir Immune Defic Syndr VL - 58 UR - https://doi.org/10.1097/QAI.0b013e318227fc34 DO - 10.1097/QAI.0b013e318227fc34 ID - Sigaloff2011 ER - TY - JOUR AU - Johnson, V. A. AU - Calvez, V. AU - Gunthard, H. F. AU - Paredes, R. AU - Pillay, D. AU - Shafer, R. W. AU - Wensing, A. M. AU - Richman, D. D. PY - 2013 DA - 2013// TI - Update of the drug resistance mutations in HIV-1: March 2013 JO - Top Antivir Med VL - 21 ID - Johnson2013 ER - TY - JOUR AU - Kosakovsky Pond, S. L. AU - Posada, D. AU - Stawiski, E. AU - Chappey, C. AU - Poon, A. F. AU - Hughes, G. AU - Fearnhill, E. AU - Gravenor, M. B. AU - Leigh Brown, A. J. AU - Frost, S. D. PY - 2009 DA - 2009// TI - An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1 JO - PLoS Comput Biol VL - 5 UR - https://doi.org/10.1371/journal.pcbi.1000581 DO - 10.1371/journal.pcbi.1000581 ID - Kosakovsky Pond2009 ER - TY - JOUR AU - de Oliveira, T. AU - Deforche, K. AU - Cassol, S. AU - Salminen, M. AU - Paraskevis, D. AU - Seebregts, C. AU - Snoeck, J. AU - van Rensburg, E. J. AU - Wensing, A. M. AU - van de Vijver, D. A. AU - Boucher, C. A. AU - Camacho, R. AU - Vandamme, A. M. PY - 2005 DA - 2005// TI - An automated genotyping system for analysis of HIV-1 and other microbial sequences JO - Bioinformatics VL - 21 UR - https://doi.org/10.1093/bioinformatics/bti607 DO - 10.1093/bioinformatics/bti607 ID - de Oliveira2005 ER - TY - JOUR AU - Chi, B. H. AU - Lee, A. AU - Acosta, E. P. AU - Westerman, L. E. AU - Sinkala, M. AU - Stringer, J. S. PY - 2006 DA - 2006// TI - Field performance of a thin-layer chromatography assay for detection of nevirapine in umbilical cord blood JO - HIV Clin Trials VL - 7 UR - https://doi.org/10.1310/hct0705-263 DO - 10.1310/hct0705-263 ID - Chi2006 ER - TY - JOUR AU - Dubuisson, J. G. AU - King, J. R. AU - Stringer, J. S. AU - Turner, M. L. AU - Bennetto, C. AU - Acosta, E. P. PY - 2004 DA - 2004// TI - Detection of nevirapine in plasma using thin-layer chromatography JO - J Acquir Immune Defic Syndr VL - 35 UR - https://doi.org/10.1097/00126334-200402010-00009 DO - 10.1097/00126334-200402010-00009 ID - Dubuisson2004 ER - TY - JOUR AU - Gandhi, M. AU - Yang, Q. AU - Bacchetti, P. AU - Huang, Y. PY - 2014 DA - 2014// TI - A Low-Cost Method for Analyzing Nevirapine Levels in Hair as a Marker of Adherence in Resource-Limited Settings JO - AIDS Res Hum Retrovir VL - 30 UR - https://doi.org/10.1089/aid.2013.0239 DO - 10.1089/aid.2013.0239 ID - Gandhi2014 ER - TY - BOOK AU - George, L. AU - Muro, E. P. AU - Ndaro, A. AU - Dolmans, W. AU - Burger, D. M. AU - Kisanga, E. R. PY - 2013 DA - 2013// TI - Nevirapine Concentrations in Saliva Measured by Thin Layer Chromatography and Self-Reported Adherence in Patients on Antiretroviral Therapy at Kilimanjaro Christian Medical Centre PB - Tanzania CY - Ther Drug Monit ID - George2013 ER - TY - JOUR AU - Kaale, E. AU - Risha, P. AU - Layloff, T. PY - 2011 DA - 2011// TI - TLC for pharmaceutical analysis in resource limited countries JO - J Chromatogr A VL - 1218 UR - https://doi.org/10.1016/j.chroma.2010.12.022 DO - 10.1016/j.chroma.2010.12.022 ID - Kaale2011 ER - TY - JOUR AU - Mullangi, R. AU - Agrawal, S. AU - Srinivas, N. R. PY - 2009 DA - 2009// TI - Measurement of xenobiotics in saliva: is saliva an attractive alternative matrix? Case studies and analytical perspectives JO - Biomed Chromatogr VL - 23 UR - https://doi.org/10.1002/bmc.1103 DO - 10.1002/bmc.1103 ID - Mullangi2009 ER - TY - CHAP PY - 2014 DA - 2014// BT - VIRAMUNE® (nevirapine) tablets, for oral use; VIRAMUNE® (nevirapine) oral suspension, for oral use. Full prescribing information PB - Boehringer Ingelheim Pharmaceuticals, Inc. CY - Ridgefield, CT 06877 USA ID - ref32 ER - TY - JOUR AU - Wu, G. AU - Zaman, M. H. PY - 2012 DA - 2012// TI - Low-cost tools for diagnosing and monitoring HIV infection in low-resource settings JO - Bull World Health Organ VL - 90 UR - https://doi.org/10.2471/BLT.12.102780 DO - 10.2471/BLT.12.102780 ID - Wu2012 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/14/473/prepub UR - http://www.biomedcentral.com/1471-2334/14/473/prepub ID - ref34 ER -